Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate.

Antimicrobial Agents and Chemotherapy
Fernando de Pilla VarottiAntoniana U Krettli

Abstract

A new synthetic antimalarial drug, a salt derived from two antimalarial molecules, mefloquine (MQ) and artesunate (AS), here named MEFAS, has been tested for its pharmacological activity. Combinations of AS plus MQ hydrochloride are currently being used in areas with drug-resistant Plasmodium falciparum parasites; although AS clears parasitemia in shorter time periods than any other antimalarial drug, it does not cure infected patients; in addition, MQ causes side effects and is rather expensive, important problems considering that malaria affects mostly populations in poor countries. Here, we show that MEFAS is more effective than the combination of AS and MQ, tested in parallel at different mass proportions, against P. falciparum (chloroquine-resistant clone W2 and chloroquine-sensitive clone 3D7) in vitro and in mice infected with Plasmodium berghei, promoting cure of this infection. MEFAS tested against HepG2 hepatoma cells exhibited lower toxicity than the antimalarials AS and MQ alone or combined. Possible targets of MEFAS have been studied by confocal microscopy using fluorescent probes (Fluo-4 AM and BCECF-AM) in P. falciparum synchronous culture of W2-infected red blood cells. Dynamic images show that MEFAS exhibited i...Continue Reading

References

Dec 1, 1979·Antimicrobial Agents and Chemotherapy·R E DesjardinsJ D Chulay
Aug 20, 1976·Science·W Trager, J B Jensen
Feb 28, 2001·Biochemical Pharmacology·S L SmithW G McLean
Mar 20, 2002·Accounts of Chemical Research·Anne RobertBernard Meunier
Apr 10, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ashley M Croft, Andrew Herxheimer
May 22, 2002·Journal of Ethnopharmacology·Maria do Céu de MadureiraVirgílio do Rosário
May 29, 2002·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·K Kirk, K J Saliba
May 30, 2002·The Biochemical Journal·Timothy J EganJason C Walden
Nov 13, 2002·The Journal of Biological Chemistry·Kevin J SalibaKiaran Kirk
Jan 18, 2003·Cell Calcium·Fernando P VarottiCélia R S Garcia
Jul 16, 2003·Journal of Ethnopharmacology·V F Andrade-NetoA U Krettli
Aug 22, 2003·Nature·U Eckstein-LudwigS Krishna
Dec 12, 2003·Molecular and Biochemical Parasitology·Tyler N BennettPaul D Roepe
Feb 26, 2004·Bioorganic & Medicinal Chemistry·Chandan SinghSunil K Puri
Jul 21, 2004·Lancet·Peter Gottfried Kremsner, Sanjeev Krishna
Oct 1, 2005·BMJ : British Medical Journal·Grace MalengaChristopher J M Whitty
Jun 24, 2006·The EMBO Journal·Petra RohrbachMichael Lanzer
Oct 13, 2006·PLoS Medicine·Virginia WisemanChristopher J M Whitty
Nov 10, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·N J White
Jan 12, 2007·European Journal of Pharmacology·Anderson Assunção AndradeAntoniana Ursine Krettli
Jan 24, 2007·Antimicrobial Agents and Chemotherapy·Françoise Benoit-VicalBernard Meunier
Aug 2, 2007·Accounts of Chemical Research·Bernard Meunier
Sep 8, 2007·Malaria Journal·Christopher V PlowePhilip J Rosenthal
Jul 9, 2008·Malaria Journal·Guoqing ZhangLinhua Tang

❮ Previous
Next ❯

Citations

Jan 29, 2014·European Journal of Medicinal Chemistry·Guilherme R PereiraAlaíde Braga de Oliveira
Feb 15, 2011·Bioorganic & Medicinal Chemistry Letters·Marli C LombardCarmen A Lategan
Oct 19, 2010·Bioorganic & Medicinal Chemistry Letters·Deuk Kyu MoonGary H Posner
Jul 20, 2010·Trends in Parasitology·Sanjeev KrishnaHenry Staines
Mar 19, 2016·Bioorganic & Medicinal Chemistry Letters·Rita C C CarvalhoNúbia Boechat
Jul 21, 2015·Bioorganic & Medicinal Chemistry·Luiz C S PinheiroAntoniana U Krettli
Jun 15, 2011·Chemical Biology & Drug Design·Flaviane F HilárioFernando de Pilla Varotti
Apr 12, 2014·Chemical Biology & Drug Design·Gillian M FisherSally-Ann Poulsen
May 8, 2014·Chemical Biology & Drug Design·Núbia BoechatAntoniana U Krettli
Jun 4, 2014·Chemical Biology & Drug Design·Ewa ŻesławskaFrançoise Benoit-Vical
Mar 27, 2010·Bioorganic & Medicinal Chemistry·Salvatore NicolettiIan H Gilbert
Sep 3, 2013·International Journal of Medical Microbiology : IJMM·Melanie LödigeAnn-Kristin Mueller
Nov 14, 2012·Memórias do Instituto Oswaldo Cruz·Anna Caroline C AguiarAntoniana U Krettli
May 9, 2018·Expert Opinion on Drug Discovery·Wilian Augusto CortopassiAntoniana Ursine Krettli
Jun 7, 2018·Anais Da Academia Brasileira De Ciências·Luiz C S PinheiroNubia Boechat
Feb 24, 2016·Antimicrobial Agents and Chemotherapy·Julia Penna-CoutinhoAntoniana Ursine Krettli
May 8, 2019·Drug and Chemical Toxicology·Daniely Alves de LimaFrancislaine Aparecida Dos Reis Lívero
Oct 28, 2019·Current Topics in Medicinal Chemistry·Kamilla Rodrigues RogerioNubia Boechat
May 8, 2020·Future Medicinal Chemistry·Ishan WadiAbhinav Sinha
Jul 9, 2020·Parasitology Research·J O AdebayoS O Malomo
Dec 12, 2017·Journal of Tropical Medicine·Tatiane Freitas BorgatiAlaíde Braga de Oliveira
Nov 27, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Luiz C S PinheiroNubia Boechat
Mar 20, 2019·Mini Reviews in Medicinal Chemistry·Akranth MarellaMd Mumtaz Alam
Jan 29, 2021·European Journal of Medicinal Chemistry·Om P S PatelLesetja J Legoabe
Jul 2, 2019·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Maja BeusBranka Zorc
Feb 10, 2019·Bioorganic & Medicinal Chemistry·Renata M R J da SilvaNubia Boechat

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.